Kielstein, Jan T.
Pontremoli, Roberto
Burnier, Michel
Funding for this research was provided by:
University of Lausanne
Article History
Accepted: 14 September 2020
First Online: 31 October 2020
Compliance with Ethical Standards
:
: JK has received research funding from ExThera Medical, Infectopharm, and has received speaker fees from Vifor, ExThera Medical, Amgen; stock of ChemoCentryx.RP has received consulting and speaker fees from Menarini International.MB has received consulting and speaker fees from Menarini International.
: This article does not contain any studies with human or animal subjects performed by any of the authors.